116 related articles for article (PubMed ID: 2128051)
21. The extracerebral dopamine antagonist domperidone block the suppressive effect of bromocriptine on prolactin and TSH secretion in man.
Svet-Moldavsky I; Svet-Moldavsky G; Zinzar S; Holland J; Vergara C; Arlin Z; Koziner B; Clarkson B
Biomedicine; 1981 Oct; 35(5):142-4. PubMed ID: 6797487
[TBL] [Abstract][Full Text] [Related]
22. Bromocriptine treatment of hyperprolactinaemic hypogonadism.
Thorner MO; Besser GM
Acta Endocrinol Suppl (Copenh); 1978; 216():131-46. PubMed ID: 347858
[TBL] [Abstract][Full Text] [Related]
23. Decreased prolactin responsiveness to thyrotrophin-releasing hormone and metoclopramide in hyperthyroidism.
Röjdmark S; Carlsson A
Acta Endocrinol (Copenh); 1985 Oct; 110(2):221-6. PubMed ID: 2998132
[TBL] [Abstract][Full Text] [Related]
24. The effects of dopaminergic blockade on serum TSH and prolactin levels in thyrotoxicosis.
Swart S; O'Malley BP; Vora J; Barnett DB; Rosenthal FD
Acta Endocrinol (Copenh); 1984 Jul; 106(3):330-5. PubMed ID: 6429989
[TBL] [Abstract][Full Text] [Related]
25. Catecholamines and pituitary function. IV. Effects of low-dose dopamine infusion and long-term bromocriptine treatment on the abnormal thyrotroph (TSH) dynamics in patients with pathological hyperprolactinaemia.
Nicoletti I; Filipponi P; Fedeli L; Ambrosi F; Giammartino C; Spinozzi F; Santeusanio F
Acta Endocrinol (Copenh); 1986 Feb; 111(2):154-61. PubMed ID: 3082094
[TBL] [Abstract][Full Text] [Related]
26. Diminished prolactin reserve with myotonic dystrophy.
May PB; Renny A; Bastek J; Giglio W; Schneider G; Ertel N
J Endocrinol Invest; 1980; 3(4):415-8. PubMed ID: 6782154
[TBL] [Abstract][Full Text] [Related]
27. Hyperprolactinaemia and female infertility.
Godó G
Acta Med Hung; 1984; 41(4):185-93. PubMed ID: 6440115
[TBL] [Abstract][Full Text] [Related]
28. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
Carey RM; Thorner MO; Ortt EM
J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
[TBL] [Abstract][Full Text] [Related]
29. Pituitary responsiveness to LHRH and TRH in men: effect of bromocriptine and clomiphene treatment.
Rönnberg L; Ylikorkala O
Int J Androl; 1983 Jun; 6(3):235-9. PubMed ID: 6411626
[TBL] [Abstract][Full Text] [Related]
30. Does bromocriptine block thyrotropin-releasing hormone-induced prolactin release during pregnancy?
Ylikorkala O; Kivinen S; Rönnberg L; Viinikka L
J Clin Endocrinol Metab; 1980 Mar; 50(3):600-2. PubMed ID: 6766949
[TBL] [Abstract][Full Text] [Related]
31. Prolactin response to thyrotropin-releasing hormone in normoprolactinemic patients with ovulatory dysfunction and its use for selection of candidates for bromocriptine therapy.
Steinberger E; Nader S; Rodriguez-Rigau L; Ayala C; Smith K
J Endocrinol Invest; 1990 Sep; 13(8):637-42. PubMed ID: 2148756
[TBL] [Abstract][Full Text] [Related]
32. Enhanced prolactin responsiveness to galanin in patients with Cushing's disease.
Invitti C; Pecori Giraldi F; Tagliaferri A; Scacchi M; Dubini A; Cavagnini F
Clin Endocrinol (Oxf); 1993 Aug; 39(2):213-6. PubMed ID: 7690312
[TBL] [Abstract][Full Text] [Related]
33. Dopamine agonist- and antagonist-induced modulation of pituitary gonadotrophin releasing hormone receptors are independent of changes in serum prolactin.
Clayton RN; Bailey LC
J Endocrinol; 1984 Aug; 102(2):215-23. PubMed ID: 6086802
[TBL] [Abstract][Full Text] [Related]
34. Comparison of metoclopramide with other dynamic tests of prolactin secretion.
Sowers JR; McCallum RW; Hershman JM; Carlson HE; Sturdevant RA; Meyer N
J Clin Endocrinol Metab; 1976 Sep; 43(3):679-81. PubMed ID: 821965
[TBL] [Abstract][Full Text] [Related]
35. Oestrogen modulation of gonadotrophin and prolactin release in women with anovulation and their responses to clomiphene.
Kandeel FR; Butt WR; Rudd BT; Lynch SS; London DR; Edwards RL
Clin Endocrinol (Oxf); 1979 Jun; 10(6):619-35. PubMed ID: 383317
[TBL] [Abstract][Full Text] [Related]
36. A giant prolactinoma and the effect of chronic bromocriptine therapy on basal and TRH-stimulated serum prolactin levels.
Barrera CM; Ruiz AE; Banks WA
Horm Res; 1991; 35(3-4):167-9. PubMed ID: 1806471
[TBL] [Abstract][Full Text] [Related]
37. Prolonged secretion of prolactin in response to thyrotrophin-releasing hormone after hypothalamo-pituitary disconnection in the ewe.
Thomas GB; Cummins JT; Hammond JM; Horton RJ; Clarke IJ
J Endocrinol; 1986 Dec; 111(3):433-8. PubMed ID: 3100711
[TBL] [Abstract][Full Text] [Related]
38. [Role of TRH or metoclopramide loading test in the diagnosis of so-called occult or latent hyperprolactinemia].
Aisaka K; Ando S; Kokuho K; Kaneda S; Tawada T; Yoshida K; Mori H
Nihon Naibunpi Gakkai Zasshi; 1987 Jul; 63(7):853-61. PubMed ID: 3119381
[TBL] [Abstract][Full Text] [Related]
39. Effects of oral and intravenous TRH and metoclopramide on PRL and TSH secretion in women.
Kauppila A; Ylikorkala O
Clin Endocrinol (Oxf); 1982 Dec; 17(6):617-23. PubMed ID: 6819904
[TBL] [Abstract][Full Text] [Related]
40. Plasma prolactin responses to thyrotropin-releasing hormone in patients with breast cancer.
Ohgo S; Kato Y; Chihara K; Imura H
Cancer; 1976 Mar; 37(3):1412-6. PubMed ID: 816451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
